Abhiflax Pharma Chem Private Limited

Abhiflax Pharma Chem proudly distributes Imipenem and Cilastatin Injection IP as a dedicated C&F partner of HAB Pharmaceuticals and Signature Lifesciences. This powerful combination antibiotic is widely relied upon in hospitals for the treatment of moderate to severe bacterial infections, especially those caused by resistant or mixed organisms.

Imipenem, a broad-spectrum carbapenem, delivers strong bactericidal activity against gram-positive, gram-negative, and anaerobic pathogens. Cilastatin enhances its effectiveness by preventing the renal degradation of Imipenem, ensuring optimal therapeutic levels in the body. Together, they are commonly used to treat complicated intra-abdominal infections, lower respiratory tract infections, urinary tract infections, septicemia, skin and soft tissue infections, and gynecological infections.

Manufactured by HAB Pharmaceuticals and Signature Lifesciences under strict GMP standards, the injection undergoes rigorous testing for potency, sterility, and stability. This ensures consistent, high-quality performance in critical-care settings.

As a trusted C&F Distributor, Abhiflax Pharma Chem ensures reliable availability, temperature-controlled storage, and timely delivery, supporting hospitals and healthcare providers in maintaining uninterrupted patient care. Through efficient logistics and customer-focused service, the company helps ensure that this essential antibiotic remains accessible where it is needed most.